Post-doctoral and PhD student positions: Translational Research on Disorders of Hemostasis and Thrombosis

 
University of Geneva Faculty of Medicine
Department of Genetic Medicine and Development

Published
WorkplaceGeneva, Lake Geneva region, Switzerland
Category
Position
Job Start1.03.2021

We are studying disorders of hemostasis and thrombosis using whole exome sequencing and functional/structural analyses of clot properties in patient samples. Our major interest is in disorders affecting fibrinogen, both quantitative and qualitative. With fibrin, produced by thrombin-mediated cleavage, fibrinogen plays important roles in many physiological processes. The formation of a stable blood clot, containing polymerized and cross-linked fibrin, is crucial to prevent blood loss and drive wound healing upon vascular injury. The fibrin clot structure, which can be influenced by a large number of variables, has been linked to cardiovascular disease risk.

Requirements

We are looking for motivated candidates with qualifications in Biomedical Sciences or Biophysics interested in translating results obtained from basic medical science studies into a better knowledge of patient phenotypes towards personalised treatments. Experience in Bioinformatics or Statistics is a plus.

We offer

Two positions, one post-doctoral, one for a PhD student, are available immediately in the laboratory of Prof. Marguerite Neerman-Arbez (UNIGE) and Dr. Alessandro Casini (HUG).
The Faculty of Medicine at the University of Geneva offers a stimulating and competitive scientific work environment with state of the art infrastructures and core facilities.

Contact and Address

Interested candidates should send their CV, letter of motivation and the contact details of three referees by email to Marguerite.Neerman-Arbezunige.ch or Alessandro.Casinihcuge.ch

Email

Web

www.ige3.unige.ch/neerman-arbez.php
 
In your application, please refer to myScience.de and reference JobID 161243.

This site uses cookies and analysis tools to improve the usability of the site. More information. |